Free Trial
→ Elon Takes Aim at Social Security (From Altimetry) (Ad) Free SXTP Stock Alerts

60 Degrees Pharmaceuticals (SXTP) SEC Filings & 10K Form

60 Degrees Pharmaceuticals logo
$0.45 -0.02 (-4.74%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$0.45 +0.00 (+0.89%)
As of 02/21/2025 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent 60 Degrees Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
02/14/2025
4:21 PM		60 Degrees Pharmaceuticals (Subject)
60 DEGREES PHARMACEUTICALS, INC. (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
Form SCHEDULE 13G/A
02/11/2025
4:23 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form D
Notice of Exempt Offering of Securities 
02/11/2025
3:53 PM		60 Degrees Pharmaceuticals (Subject)
60 DEGREES PHARMACEUTICALS, INC. (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
Form SCHEDULE 13G
02/06/2025
9:04 AM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 424B5
02/03/2025
3:05 PM		60 Degrees Pharmaceuticals (Subject)
60 DEGREES PHARMACEUTICALS, INC. (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
Form SCHEDULE 13G
01/30/2025
4:30 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2025
7:28 AM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 424B5
01/24/2025
3:51 PM		60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
MILLER TYRONE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2025
3:52 PM		60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
DOW GEOFFREY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2025
3:58 PM		60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
MILLER TYRONE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2025
4:00 PM		60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
DOW GEOFFREY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
3:05 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
7:35 PM		60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
XU CHERYL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
4:07 PM		60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
DOW GEOFFREY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
5:14 PM		60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
DOW GEOFFREY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
12:44 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
3:01 PM		60 Degrees Pharmaceuticals (Subject)
60 DEGREES PHARMACEUTICALS, INC. (Subject)
Knight Therapeutics Inc (Filed by)
Form SC 13G/A
11/06/2024
4:26 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
2:46 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form DEF 14A
10/08/2024
7:17 AM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
9:56 AM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form PRE 14A
09/30/2024
11:15 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form EFFECT
09/19/2024
3:30 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/11/2024
3:46 PM		60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
XU CHERYL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2024
2:59 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
9:29 AM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
11:03 AM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
3:15 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
12:21 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 424B5
07/24/2024
4:05 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 424B5
07/22/2024
10:23 AM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 424B5
07/18/2024
11:15 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form EFFECT
07/16/2024
4:28 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2024
4:02 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/09/2024
2:37 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
4:06 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2024
4:26 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2024
1:15 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form DEF 14A
05/21/2024
7:22 PM		60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
MILLER TYRONE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
7:23 PM		60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
TOOVEY STEPHEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
7:23 PM		60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
XU CHERYL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Shocking Elon Move: Bigger than DOGE? (Ad)

After saving free speech with his acquisition of Twitter… And after blowing everyone’s minds with his recent DOGE moves… What Elon Musk is about to do next could not only shock the world… But also put an extra $30,000 a year in your pocket.

Click here to see the details BEFORE March 17th…
05/21/2024
7:18 PM		60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
Allen Charles W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
7:19 PM		60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
DOW GEOFFREY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
7:20 PM		60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
FIELD PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
10:56 AM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2024
6:19 PM		60 Degrees Pharmaceuticals (Subject)
60 DEGREES PHARMACEUTICALS, INC. (Subject)
KNIGHT THERAPEUTICS INTERNATIONAL SA (Filed by)
Form SC 13G/A
04/03/2024
5:00 PM		60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
Knight Therapeutics Inc (Reporting)
KNIGHT THERAPEUTICS INTERNATIONAL SA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
1:32 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:SXTP) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners
The Real Hillbilly Elegy
The mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...
Porter & Company | Sponsored
$5,000 DOGE check?
Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a porti...
Altimetry | Sponsored
Elon’s “New Gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...
True Market Insiders | Sponsored
Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”
Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...
Colonial Metals | Sponsored
This Crypto Is Set to Explode in February
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...
Crypto 101 Media | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Buy NVDA Now?
After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...
Chaikin Analytics | Sponsored
2025 AI Blueprint features Nvidia’s march to $5 trillion
Nvidia is now one of the most valuable companies in the world. It currently ranks second, just behind Apple...
Weiss Ratings | Sponsored